Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Evaluation of the clinical performance of Metagenomic Next-generation sequencing for diagnosis of invasive fungal diseases after CAR-T cells infusion

Yu Zhang, Yifan Zhao, Qianyi Zhou, Mengnan Li, Xiaomei Zhang, Xiaoyuan He, Mingfeng Zhao

Blood (2025) 146 (Supplement 1): 7671.

https://doi.org/10.1182/blood-2025-7671

Published: 2025

Journal Articles

A study on the efficacy, safety and mechanism of venetoclax combined with CAR-T targeting CLL1 in the treatment of Acute Myeloid Leukemia

Bing Wang, Mengnan Li, Xiaoyuan He, Xiaomei Zhang, Yu Zhang, Tao Zhang, Jile Liu, Mingfeng Zhao

Blood (2025) 146 (Supplement 1): 3453.

https://doi.org/10.1182/blood-2025-3453

Published: 2025

Journal Articles

This is a title in sentence case:early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies

Juanxia Meng, Xiaoyuan He, Mingfeng Zhao

Blood (2025) 146 (Supplement 1): 7660.

https://doi.org/10.1182/blood-2025-7660

Published: 2025

Journal Articles

Kte-X19 in relapsed or refractory adult B-cell acute lymphoblastic leukemia in the Chinese population: 6-month analysis of a phase II multicenter trial

Meng Lv, Hao Jiang, Yuhua Li, Yicheng Zhang, Jie Jin, Hongsheng Zhou, Kailin Xu, Mingfeng Zhao, Xin Du, Kai Hu, Jun Hu, Jinghua Zhao, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 1563.

https://doi.org/10.1182/blood-2025-1563

Published: 2025

Journal Articles

Dual-armoring of CLL-1 CAR-T cells with IL-18 and an RQR8 suicide switch enhances efficacy and safety in Acute Myeloid Leukemia

Wenyi Lu, Bing Cao, Xin Jin, Yuanyuan Hao, Lei Zhang, Wei Cheng, Wei Li, Zhenxin Zhao, Zhoufeng Huang, Wenyan Li, Yuanbo Liu, Mingfeng Zhao, Zunmin Zhu

Blood (2025) 146 (Supplement 1): 4124.

https://doi.org/10.1182/blood-2025-4124

Published: 2025

Journal Articles

This is a title in sentence case:synnotch CD123 and CLL1 CAR-T can specifically target AML to avoid the off-target effects

Rui Zhang, Mengnan Li, Xiaomei Zhang, Mingfeng Zhao

Blood (2025) 146 (Supplement 1): 4111.

https://doi.org/10.1182/blood-2025-4111

Published: 2025

Journal Articles

Efficacy and Safety of CAR-T Therapy Targeting CLL1 in Patients with Extramedullary Diseases of Acute Myeloid Leukemia

Yifan Zhao, Xue Bai, Shujing Guo, Xiaomei Zhang, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 2082.

https://doi.org/10.1182/blood-2024-205229

Published: 2024

Journal Articles

Variables Associated with Outcomes in Patients with Chronic Neutrophilic Leukemia with CSF3R T618I : A Multi-Centre Retrospective Study

Blood (2024) 144 (Supplement 1): 1793.

https://doi.org/10.1182/blood-2024-207591

Published: 2024

Journal Articles

CD19 CAR-T Therapy for Patients with Relapsed or Refractory Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study

Jinglei Yu, Fengmei Song, Mingming Zhang, Mingfeng Zhao, Wei Sang, Songfu Jiang, Lixin Wang, Xingbing Wang, He Huang, Yongxian Hu, Guoqing Wei

Blood (2024) 144 (Supplement 1): 4201.

https://doi.org/10.1182/blood-2024-210616

Published: 2024

Journal Articles

Modified Dual CLL1-CD15 and CLL1-CD16 Icar-T Cells for Mitigating Granulocytopenia Toxicities in the Treatment of Acute Myeloid Leukemia

Rui Zhang, Yifan Zhao, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 372.

https://doi.org/10.1182/blood-2024-205192

Published: 2024

Journal Articles

Oncolytic Herpes Simplex Virus-Loaded CD19 CAR-T Cells Improves the Therapeutic Effect of Diffuse Large B-Cell Lymphoma

Jile Liu, Xiaomei Zhang, Rui Sun, Shujing Guo, Yuxin An, Yifan Zhao, Mohan Zhao, Hongkai Zhang, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 4810.

https://doi.org/10.1182/blood-2024-205138

Published: 2024

Journal Articles

Split CAR-T Cells Targeting CD312 and TIM-3 for AML to Reduce the Risk of Antigen Escape

Xiao Chai, Xiaomei Zhang, Mingfeng Zhao, Rui Zhang

Blood (2024) 144 (Supplement 1): 4795.

https://doi.org/10.1182/blood-2024-206777

Published: 2024

Journal Articles

Development of ThisCART371 Targeting CLL1 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Xiaomei Zhang, Xia Xiao, Hairong Lv, Xue Bai, Pengjiang Liu, Yedi Pu, Juanxia Meng, Haibo Zhu, Zhao Wang, Huan Zhang, Xiaoyuan He, Yu Zhang, Cuicui Lv, Yifan Zhao, Shujing Guo, Jile Liu, Mohan Zhao, Jun Li, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 7210.

https://doi.org/10.1182/blood-2024-204381

Published: 2024

Journal Articles

Distribution of Infectious Complications Following CLL1 CAR-T Cell Therapy for R/R AML: A Single-Center Experience

Jianmei Xu, Huan Zhang, Yifan Zhao, Xiaomei Zhang, Shujing Guo, Hairong Lv, Xia Xiao, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 6018.

https://doi.org/10.1182/blood-2024-202265

Published: 2024

Journal Articles

Evaluating the Effectiveness of Risk Adjustment Using Dynamic Frailty Assessment in Treating Newly Diagnosed Multiple Myeloma in Elderly Patients

Jianmei Xu, Hua Xue, Songying Zhao, Jing Wang, Huimei Guo, Jiangbo Zhang, Jia Liu, Mingjie Tian, Luoming Hua, Mingfeng Zhao

Blood (2023) 142 (Supplement 1): 6644.

https://doi.org/10.1182/blood-2023-185684

Published: 2023

Journal Articles

Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 2100.

https://doi.org/10.1182/blood-2023-173926

Published: 2023

Journal Articles

Efficacy Analysis of Ixazomib-Based Regimens Based on Dynamic Frailty Assessment in Elderly and Frail Patients with Newly Diagnosed Multiple Myeloma

Jianmei Xu, Hua Xue, Songying Zhao, Jing Wang, Huimei Guo, Jiangbo Zhang, Jia Liu, Luoming Hua, Mingjie Tian, Mingfeng Zhao

Blood (2023) 142 (Supplement 1): 6690.

https://doi.org/10.1182/blood-2023-185230

Published: 2023

Journal Articles

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Blood (2023) 142 (Supplement 1): 2106.

https://doi.org/10.1182/blood-2023-180387

Published: 2023

Journal Articles

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Blood (2022) 139 (23): 3376–3386.

https://doi.org/10.1182/blood.2021013733

Published: 2022

Includes: Supplemental data

Journal Articles

Low-Dose Decitabine Plus Venetoclax Maintenance Therapy Can Decrease the Relapse after Allogeneic Stem Cell Transplantation for MRD Positive High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Yunxiong Wei, Yaqing Cao, Xin Jin, Xiaoyuan He, Rui Sun, Xia Xiong, Wenyi Lu, MD, Xin Li, Xia Xiao, MD, Hairong Lyu, Mingfeng Zhao, MDPhD

Blood (2020) 136 (Supplement 1): 33.

https://doi.org/10.1182/blood-2020-140359

Published: 2020

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Evaluation of the clinical performance of Metagenomic Next-generation sequencing for diagnosis of invasive fungal diseases after CAR-T cells infusion

A study on the efficacy, safety and mechanism of venetoclax combined with CAR-T targeting CLL1 in the treatment of Acute Myeloid Leukemia

This is a title in sentence case:early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies

Kte-X19 in relapsed or refractory adult B-cell acute lymphoblastic leukemia in the Chinese population: 6-month analysis of a phase II multicenter trial

Dual-armoring of CLL-1 CAR-T cells with IL-18 and an RQR8 suicide switch enhances efficacy and safety in Acute Myeloid Leukemia

This is a title in sentence case:synnotch CD123 and CLL1 CAR-T can specifically target AML to avoid the off-target effects

Efficacy and Safety of CAR-T Therapy Targeting CLL1 in Patients with Extramedullary Diseases of Acute Myeloid Leukemia

Variables Associated with Outcomes in Patients with Chronic Neutrophilic Leukemia with CSF3R T618I : A Multi-Centre Retrospective Study

CD19 CAR-T Therapy for Patients with Relapsed or Refractory Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study

Modified Dual CLL1-CD15 and CLL1-CD16 Icar-T Cells for Mitigating Granulocytopenia Toxicities in the Treatment of Acute Myeloid Leukemia

Oncolytic Herpes Simplex Virus-Loaded CD19 CAR-T Cells Improves the Therapeutic Effect of Diffuse Large B-Cell Lymphoma

Split CAR-T Cells Targeting CD312 and TIM-3 for AML to Reduce the Risk of Antigen Escape

Development of ThisCART371 Targeting CLL1 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Distribution of Infectious Complications Following CLL1 CAR-T Cell Therapy for R/R AML: A Single-Center Experience

Evaluating the Effectiveness of Risk Adjustment Using Dynamic Frailty Assessment in Treating Newly Diagnosed Multiple Myeloma in Elderly Patients

Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation

Efficacy Analysis of Ixazomib-Based Regimens Based on Dynamic Frailty Assessment in Elderly and Frail Patients with Newly Diagnosed Multiple Myeloma

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Low-Dose Decitabine Plus Venetoclax Maintenance Therapy Can Decrease the Relapse after Allogeneic Stem Cell Transplantation for MRD Positive High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only